Investigation of IMPDH2 overexpression in renal cell carcinoma (RCC) & its association with oncologic outcomes.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.7_suppl.594
Abstract: 594 Background: Approximately 40% of locoregional RCC patients relapse after nephrectomy leading to lower 5 year survival rates of 53% (stage III) & 8% (metastatic). No biomarkers of prognostic significance are in clinical use at… read more here.
Keywords: rcc; oncologic outcomes; impdh2 overexpression; cell ... See more keywords